Digital Journal sits down with LexaGene CEO Dr. Regan to discuss the challenge of antibiotic resistance threats and how LexaGene’s analyzer can help improve antibiotic stewardship.
![fc9eaf08-5d8b-4c20-a73c-516188a3e81a-e1565209824158[1]](https://lexagene.com/wp-content/uploads/2021/11/fc9eaf08-5d8b-4c20-a73c-516188a3e81a-e15652098241581.jpeg)
Digital Journal Antibiotic Resistance Q&A
LexaGene
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
Upcoming Events
No events in this category to show at this time.
Latest Resources
LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.